Index of artpub/2024/311627/

Spelman, Tim
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom
2024
https://ddd.uab.cat/record/311627